Research Webinar Series: Update of MuSK Myasthenia Gravis Phase 1 Clinical Trial (MusCAARTes)

Поделиться
HTML-код
  • Опубликовано: 8 сен 2024

Комментарии • 3

  • @asharani-qh2fi
    @asharani-qh2fi Год назад +1

    Great hope with this therapy.

  • @simonsteen-andersen3181
    @simonsteen-andersen3181 Год назад

    Could Myasthenia Gravis due to LRP4- autoantibodies also benefit from this treatment?

    • @myastheniagravisfoundation8053
      @myastheniagravisfoundation8053  Год назад

      Physicians do proscribe "off label," with insurance approval, when other medications aren't working. However, it's important to note that this is a research study, so it's not yet approved for use beyond those enrolled in the trial.